DK1587526T3 - MNTF-peptider og sammensætninger og anvendelsesmåder - Google Patents
MNTF-peptider og sammensætninger og anvendelsesmåderInfo
- Publication number
- DK1587526T3 DK1587526T3 DK04704005.0T DK04704005T DK1587526T3 DK 1587526 T3 DK1587526 T3 DK 1587526T3 DK 04704005 T DK04704005 T DK 04704005T DK 1587526 T3 DK1587526 T3 DK 1587526T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- methods
- directed
- modulating
- growth
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 210000002569 neuron Anatomy 0.000 abstract 2
- 230000000508 neurotrophic effect Effects 0.000 abstract 1
- 230000002276 neurotropic effect Effects 0.000 abstract 1
- 230000035899 viability Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44177203P | 2003-01-21 | 2003-01-21 | |
| PCT/US2004/001468 WO2004065410A2 (en) | 2003-01-21 | 2004-01-21 | Mntf peptides and compositions and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1587526T3 true DK1587526T3 (da) | 2012-02-06 |
Family
ID=32771972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04704005.0T DK1587526T3 (da) | 2003-01-21 | 2004-01-21 | MNTF-peptider og sammensætninger og anvendelsesmåder |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7183373B2 (https=) |
| EP (1) | EP1587526B1 (https=) |
| JP (3) | JP2006516287A (https=) |
| AT (1) | ATE530191T1 (https=) |
| AU (1) | AU2004205659B2 (https=) |
| CA (1) | CA2506855C (https=) |
| DK (1) | DK1587526T3 (https=) |
| ES (1) | ES2375797T3 (https=) |
| WO (1) | WO2004065410A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6841531B2 (en) | 1996-09-27 | 2005-01-11 | Genervon Biopharmaceuticals Llc | Methods and use of motoneuronotrophic factors |
| EP1587526B1 (en) * | 2003-01-21 | 2011-10-26 | Genervon Biopharmaceuticals LLC | Mntf peptides and compositions and methods of use |
| WO2007058982A2 (en) * | 2005-11-10 | 2007-05-24 | Genervon Biopharmaceuticals Llc | Mntf differentiation and growth of stem cells |
| US8340193B2 (en) * | 2006-08-04 | 2012-12-25 | Microsoft Corporation | Wyner-Ziv and wavelet video coding |
| WO2008057609A2 (en) * | 2006-11-10 | 2008-05-15 | Genervon Biopharmaceuticals Llc | Methods of treating neuronal disorders using mntf peptides and analogs thereof |
| EP2000134A1 (en) * | 2007-06-06 | 2008-12-10 | Neuraxo Biopharmaceuticals GmbH | Use of a substance for the improvement of pns lesions |
| US20090233295A1 (en) * | 2008-01-29 | 2009-09-17 | Elias Georges | Trim59 directed diagnostics for neoplastic disease |
| CN101952306B (zh) * | 2008-02-21 | 2014-09-10 | 皮护神经科学协会 | Mntf肽的化妆和皮肤病制剂 |
| US8846615B2 (en) * | 2008-02-21 | 2014-09-30 | Genervon Biopharmaceuticals, LLC | MNTF peptides |
| WO2016210123A1 (en) | 2015-06-26 | 2016-12-29 | Genervon Biopharmaceuticals, LLC | Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease |
| WO2022244757A1 (ja) | 2021-05-18 | 2022-11-24 | 株式会社Ｌｔｔバイオファーマ | 抗癌剤の投与に伴う障害を治療又は予防するための医薬組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6841531B2 (en) * | 1996-09-27 | 2005-01-11 | Genervon Biopharmaceuticals Llc | Methods and use of motoneuronotrophic factors |
| US6309877B1 (en) * | 1996-09-27 | 2001-10-30 | Km Biotech, Inc. | Polynucleotides encoding motoneuronotrophic factors |
| EP1587526B1 (en) * | 2003-01-21 | 2011-10-26 | Genervon Biopharmaceuticals LLC | Mntf peptides and compositions and methods of use |
-
2004
- 2004-01-21 EP EP04704005A patent/EP1587526B1/en not_active Expired - Lifetime
- 2004-01-21 AT AT04704005T patent/ATE530191T1/de active
- 2004-01-21 ES ES04704005T patent/ES2375797T3/es not_active Expired - Lifetime
- 2004-01-21 US US10/541,343 patent/US7183373B2/en not_active Expired - Lifetime
- 2004-01-21 DK DK04704005.0T patent/DK1587526T3/da active
- 2004-01-21 CA CA2506855A patent/CA2506855C/en not_active Expired - Lifetime
- 2004-01-21 JP JP2006501057A patent/JP2006516287A/ja not_active Withdrawn
- 2004-01-21 WO PCT/US2004/001468 patent/WO2004065410A2/en not_active Ceased
- 2004-01-21 AU AU2004205659A patent/AU2004205659B2/en not_active Ceased
-
2007
- 2007-01-25 US US11/657,815 patent/US7795215B2/en not_active Expired - Lifetime
-
2010
- 2010-09-27 JP JP2010215438A patent/JP4913895B2/ja not_active Expired - Fee Related
-
2011
- 2011-10-14 JP JP2011226655A patent/JP2012046538A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004065410A3 (en) | 2004-12-16 |
| AU2004205659B2 (en) | 2009-03-26 |
| US20060052299A1 (en) | 2006-03-09 |
| WO2004065410A2 (en) | 2004-08-05 |
| US20080125373A1 (en) | 2008-05-29 |
| CA2506855A1 (en) | 2004-08-05 |
| JP2012046538A (ja) | 2012-03-08 |
| JP4913895B2 (ja) | 2012-04-11 |
| JP2006516287A (ja) | 2006-06-29 |
| US7183373B2 (en) | 2007-02-27 |
| ES2375797T3 (es) | 2012-03-06 |
| US7795215B2 (en) | 2010-09-14 |
| AU2004205659A1 (en) | 2004-08-05 |
| JP2011042659A (ja) | 2011-03-03 |
| EP1587526B1 (en) | 2011-10-26 |
| ATE530191T1 (de) | 2011-11-15 |
| CA2506855C (en) | 2013-08-27 |
| EP1587526A2 (en) | 2005-10-26 |
| EP1587526A4 (en) | 2008-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60331345D1 (de) | Probensubstrat zur biologischen untersuchung | |
| DK1587526T3 (da) | MNTF-peptider og sammensætninger og anvendelsesmåder | |
| WO2004063362A3 (en) | Cell cycle progression proteins | |
| ATE312843T1 (de) | Neues cyclosporin mit verbesserter wirkung | |
| CY1108361T1 (el) | ΣΤΑΘΕΡΟ ΣΚΕΥΑΣΜΑ ΠΟΥ ΠΕΡΙΕΧΕΙ TNFR-Fc ΚΑΙ ΑΡΓΙΝΙΝΗ | |
| ATE548022T1 (de) | Zusammensetzungen mit einer kombination von tetrapeptiden und tripeptiden | |
| DK1210411T3 (da) | Sammensætninger og fremgangsmåder til forbedret celledyrkning | |
| ATE238024T1 (de) | Zusammensetzung zur verzögerung des haarwuchses und entsprechende verwendung | |
| BG108492A (bg) | Използване на въглероден окис за подобряване на резултатите при трансплантация на тъкани и органи и потискане на апоптозата | |
| DK0835447T3 (da) | Peptider og sammensætninger, der modulerer apoptose | |
| ATE368688T1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| IS2631B (is) | Aðferðir þar sem integrín-mótlyf eru notuð til að meðhöndla margföld mergæxli og uppsog í bein af völdum mergæxla | |
| ATE411086T1 (de) | Verwendung von granulaten in kosmetischen zusammensetzungen auf basis von pyrogenisch hergestelltem siliziumdioxid | |
| NO20060464L (no) | Use of CXCL6 chemokine in the prevention or repair of cartilage defects | |
| EA200701293A1 (ru) | Терапевтическая композиция фактора роста кератиноцитов | |
| ATE445402T1 (de) | Neue verwendung von pde5-hemmern | |
| ATE416607T1 (de) | Pflanzenbewusserungssystem | |
| ATE283286T1 (de) | Adnf mischungen zur verbesserung der lernfähigkeit und der gedächtnisfunktion | |
| DE60128426D1 (de) | Zellenanordnung von Stromquellen, Verfahren zur Auswahl von Stromquellen und Digital-Analog-Wandler des Stromadditionstyps | |
| ES2194237T3 (es) | Preparaciones cosmeticas. | |
| ATE521610T1 (de) | Spiroverbindungen und -verfahren zur modulation von chemokin-rezeptor-aktivität | |
| NO942825L (no) | Polypeptider med fibronektinbindingsseter som modulatorer for sammensetting av matriks | |
| BR0307470A (pt) | fração de plasma de um animal hibernante e métodos de purificar uma molécula tendo atividade anti-infarto, de reduzir um infarto em um indivìduo de produzir e de identificar uma molécula anti-infarto e de identificar um inibidor da interação entre a bradicinina e o tipo 2 do receptor de angiotensina ii | |
| BR0316544A (pt) | Compostos calcilìticos | |
| BR0108187A (pt) | Moléculas trade e usos relacionados com as mesmas |